Suppr超能文献

多发性硬化症发病和进展中的血管合并症。

Vascular comorbidities in the onset and progression of multiple sclerosis.

作者信息

Tettey Prudence, Simpson Steve, Taylor Bruce V, van der Mei Ingrid A F

机构信息

Menzies Research Institute Tasmania, University of Tasmania, Australia.

Menzies Research Institute Tasmania, University of Tasmania, Australia.

出版信息

J Neurol Sci. 2014 Dec 15;347(1-2):23-33. doi: 10.1016/j.jns.2014.10.020. Epub 2014 Oct 16.

Abstract

Vascular comorbidities are common in the general population and are associated with adverse health outcomes. In people with multiple sclerosis (MS), an increasing amount of evidence suggests that vascular comorbidities are also common, but an association with MS risk and disability has not been conclusively established. This review aims to critically examine published data on the relationship between vascular comorbidities (including vascular risk factors) and MS. The evidence suggests an increased risk of MS in people with a high BMI during childhood or adolescence but not adulthood. People with established MS appear to have a slightly increased risk of cardiovascular disease and a greater proportion of people with MS die from cardiovascular disease, which has important implications for clinicians trying to identify risk factors for cardiovascular disease and reviewing treatment options. In relation to whether vascular comorbidities influence MS clinical disability or other aspects of the disease course, the key finding was that having type-2-diabetes, hypertension, dyslipidaemia or peripheral vascular disease at any point in the disease course may be associated with a greater progression in disability. Additionally, a negative effect of high cholesterol and triglycerides and a positive effect of higher HDL (high density lipoprotein) levels on acute inflammatory activity were observed on magnetic resonance imaging. The results of the published clinical trials of statins as an intervention in MS were however conflicting and care needs to be taken when treating people with MS with statins. Taken together, the literature seems to indicate a potential association of vascular comorbidities with MS risk and disability, but the number of prospective studies was sparse, thus precluding ascription of causality. We therefore recommend that future studies of the frequency and effects of vascular comorbidities on MS risk and disability should be prospective and objective where relevant.

摘要

血管合并症在普通人群中很常见,并与不良健康结局相关。在多发性硬化症(MS)患者中,越来越多的证据表明血管合并症也很常见,但与MS风险和残疾之间的关联尚未得到最终证实。本综述旨在严格审查已发表的关于血管合并症(包括血管危险因素)与MS之间关系的数据。证据表明,儿童期或青少年期而非成年期BMI高的人群患MS的风险增加。已确诊MS的患者患心血管疾病的风险似乎略有增加,且MS患者中死于心血管疾病的比例更高,这对试图识别心血管疾病危险因素并审查治疗方案的临床医生具有重要意义。关于血管合并症是否会影响MS的临床残疾或疾病进程的其他方面,关键发现是在疾病进程的任何阶段患有2型糖尿病、高血压、血脂异常或外周血管疾病可能与残疾进展更大有关。此外,在磁共振成像中观察到高胆固醇和甘油三酯有负面影响,而较高的高密度脂蛋白(HDL)水平对急性炎症活动有正面影响。然而,已发表的他汀类药物作为MS干预措施的临床试验结果相互矛盾,在使用他汀类药物治疗MS患者时需要谨慎。综合来看,文献似乎表明血管合并症与MS风险和残疾之间可能存在关联,但前瞻性研究数量稀少,因此无法确定因果关系。因此,我们建议未来关于血管合并症对MS风险和残疾的频率及影响的研究在相关方面应具有前瞻性和客观性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验